Morbidity of dilatation and evacuation in the second trimester: An analysis;Morbidität einzeitiger abortausräumungen im 2. Trimenon: Eine standortbestimmung

Gynakologisch-geburtshilfliche Rundschau

Volumn 45, Issue 2, 2005, Pages 107-115

  Pauli, E ^a   Haller, U ^a   Zimmermann, R ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Dilatation and evacuation; One phase evacuation of abortion; Second trimester; Termination of pregnancy; Vacuum curettage

Indexed keywords

ANTIBIOTIC AGENT; PROSTAGLANDIN;

CONTROLLED STUDY; CURETTAGE; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FEVER; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INDUCED ABORTION; MAJOR CLINICAL STUDY; MORTALITY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PREGNANCY COMPLICATION; PREGNANCY TERMINATION; REVIEW; SECOND TRIMESTER PREGNANCY; STATISTICAL SIGNIFICANCE; THROMBOEMBOLISM; THROMBOSIS; UTERINE CERVIX DISEASE; UTERUS PERFORATION; ADULT; ARTICLE; BLEEDING; COMPARATIVE STUDY; POSTOPERATIVE COMPLICATION; PREGNANCY; RETROSPECTIVE STUDY; RISK; RISK FACTOR; STATISTICS;

ABORTION, INDUCED; ADULT; BLOOD LOSS, SURGICAL; DILATATION AND CURETTAGE; FEMALE; HUMANS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; RETROSPECTIVE STUDIES; RISK; RISK FACTORS;

EID: 17844380799     PISSN: 10188843     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083785     Document Type: Review

References (38)

1. Hirsch HA, Käser O, Ikle FA: Termination of pregnancy in the second trimester; in Hirsch HA, Käser O, Ikle FA (Hrsg): Atlas of Gynecologic Surgery, Aufl 3. Stuttgart, Thieme, 1997, pp 78-82.
2. 2 gel. Int J Gynecol Obstet 1990;34:169-173.
3. Winkler M, Rath W: Aktuelles Vorgehen bei der vorzeitigen Schwangerschaftsbeendigung mit Prostaglandinen im II. und III. Trimenon. Z Geburtshilfe Neonatol 1997;201:39-42.
4. Grimes DA: Second-trimester abortions in the United States. Fam Plann Persp 1984;16:260-266.
5. Rau M: Diagnostic ultrasonography of fetal anomalies; Inauguraldissertation, Departement Pathologie der Universität, Universitätsspital Zürich, 1997.
6. Peterson WF, Berry FN, Grace MR, Gulbranson CL: Second-trimester abortion by dilatation and evacuation: An analysis of 11,747 cases. Obstet Gynecol 1983;62:185-190.
7. Grimes DA, Schulz KF, Cates W, Tyler CW: Mid-trimester abortion by dilatation and evacuation: A safe and practical alternative. N Engl J Med 1977;296:1141-1145.
8. 2α versus dilatation and evacuation. JAMA 1984;251:916-919.
9. Hodari AA, Peralta J, Quiroga PJ, Gerbi EB: Dilatation and curettage for second-trimester abortions. Am J Obstet Gynecol 1977;127: 850-854.
10. Schneider D, Halperin R, Langer R, Caspi E, Bukovsky I: Abortion at 18-22 weeks by Laminaria dilation and evacuation. Obstet Gynecol 1996;88:412-414.
11. 2. J Reprod Med 1982;27:415-419.
12. Jacot FRM, Poulin C, Bilodeau AP, Morin M, Moreau S, Gendron F, et al: A five-year experience with second-trimester induced abortions: No increase in complication rate compared to the first trimester. Am J Obstet Gynecol 1993;168:633-637.
13. Berger GS, Keith LG: Complications of second trimester abortion; in Keirse MJNC, Bennebroek Gravenhorst J, van Lith DAF, Embrey MP (Hrsg): Second Trimester Pregnancy Termination. Boerhaave Series. The Hague, Leiden University Press, 1982, pp 155-167.
14. Hodgson JE, Portman K, Quattlebaum FW: Prophylactic use of tetracycline for first trimester abortion. Obstet Gynecol 1975;54:574.
15. Stubblefield PG: Surgical techniques for uterine evacuation in first- and second-trimester abortion. Clin Obstet Gynaecol 1986;13:53-70.
16. Stubblefield PG: Pregnancy termination; in Gabbe SG, Niebyl JR, Simpson JL (Hrsg): Obstetrics: Normal and Problem Pregnancies, Aufl 2. New York, Churchill Livingstone, 1991, pp 1303-1330.
17. Amy J-J: Termination of second trimester pregnancy with prostaglandin analogues; in Keirse MJNC, Bennebroek Gravenhorst J, van Lith DAF, Embrey MP (Hrsg): Second Trimester Pregnancy Termination. Boerhaave Series. The Hague, Leiden University Press, 1982, pp 115-131.
18. Bygdeman M, Berger GS, Keith LG: Prostaglandins and midtrimester abortion; in Bygdeman M, Berger GS, Keith LG (Hrsg): Prostaglandins and Their Inhibitors in Clinical Obstetrics and Gynaecology. Boston, MPT Press, 1986, pp 288-314.
19. Bygdeman M: Prostaglandin analogues and their uses; in Elder MG (Hrsg): Baillière's Clinical Obstetrics and Gynaecology: Prostaglandins. London, Baillière Tindall, 1992, pp 893-903.
20. Embrey MP: Prostaglandin therapy for second trimester abortion: An overview of current status and recent trends; in Keirse MJNC, Bennebroek Gravenhorst J, van Lith DAF, Embrey MP (Hrsg.): Second Trimester Pregnancy Termination. Boerhaave Series. The Hague, Leiden University Press, 1982, pp 132-137.
21. Goeschen K: Behandlung mit Prostaglandinen - Allgemeines Vorgehen; in Martius G (Hrsg): Behandlung mit Prostaglandinen in Geburtshilfe und Gynäkologie. Stuttgart, Enke, 1989, pp 25-39.
22. Keirse MJNC: Therapeutic uses of prostaglandins; in Elder MG (Hrsg): Baillière's Clinical Obstetrics and Gynaecology: Prostaglandins. London, Baillière Tindall, 1992, pp 787-808.
23. Toppozada M, Ismail AAA: Intrauterine administration of drugs for termination of pregnancy in the second trimester; in Bygdeman M (Hrsg): Baillière's Clinical Obstetrics and Gynaecology: Medical Induction of Abortion. London, Baillière Tindall, 1990, pp 327-349.
24. Karim SMM, Filshie GM: Therapeutic abortion using prostaglandin F. Lancet 1970;i:157.
25. 2α. Br Med J 1972;3:146-149.
26. Miller AWF, Calder AA: Termination of pregnancy by continuous intrauterine infusion of prostaglandins. Lancet 1972;2:5-7.
27. Heinzl S: Aborteinleitung im zweiten Trimenon mit Prostaglandin-Gel. Geburtshilfe Frauenheilkd 1978;38:220-226.
28. 2: An analysis of efficacy and complications. Br J Obstet Gynaecol 1989;96:1424-1431.
29. 2α. Contraception 1993;47:475-481.
30. Lippert TH: Induction of abortion by the extraamniotic administration of prostaglandin gels. J Obstet Gynaecol 1973;80:1025-1027.
31. Steyn DW, Pienaar MP: Mid-trimester termination of pregnancy - A randomized controlled trial of two prostaglandin regimens. S Afr Med J 1993;83:737-738.
32. 2 in viscous gel to induce mid-trimester abortion. Br Med J 1975;i:240-242.
33. 2. Eur J Obstet Gynecol Reprod Biol 1986;21:165-171.
34. Schmidt W, Ditz S: Abortinduktion im 2. und 3. Schwangerschaftstrimenon; in Haller U, Kubli F, Husslein P (Hrsg): Prostaglandine in Gynäkologie und Geburtshilfe. Berlin, Springer, 1988, pp 144-122.
35. Heinzl S, Winkler C: Aborteinleitungen im zweiten und dritten Trimenon mit «Sulproston». Geburtshilfe Frauenheilkd 1981;41:231-236.
36. Rath W: Die Anwendung von Prostaglandinen zur Schwangerschaftsbeendigung im I. und II. Trimenon. Wien Klin Wochenschr 1987;99: 741-751.
37. Rath W, Ulbrich R, Kuhn W: Zervixreifung und Weheninduktion beim Schwangerschaftsabbruch im mittleren und späten II. Trimenon mittels intrazervikaler und extraamnialer Prostaglandingel-Applikation. Wien Klin Wochenschr 1985;97:486-493.
38. Hern WM: Serial multiple Laminaria and adjunctive urea in late outpatient dilatation and evacuation abortion. Obstet Gynecol 1984;63:543-549.